Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NHPIU
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
AMT-116
|
|||||
| Synonyms |
AMT-116; AMT 116; AMT116
Click to Show/Hide
|
|||||
| Organization |
Multitude Therapeutics, Inc.
|
|||||
| Drug Status |
Phase 1/2
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
7 to 8
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
CD44 antigen variant 9 (CD44v9)
|
Antigen Info | ||||
| Payload Name |
KL610023
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Conjugate Type |
Undisclosed
|
|||||
